OnDemand WTP Pricing Research

Tag: rebate management

Trump abandons proposal that would have ended certain drug rebates | STAT

Trump abandons proposal that would have ended certain drug rebates | STAT

WASHINGTON — The Trump administration on Wednesday abandoned one of its signature drug-pricing efforts: a ban on many of the rebates that drug companies pay to pharmacy benefit managers under Medicare. A White House spokesman confirmed the news to STAT after it was first reported by Axios. “Based on careful analysis and thorough consideration, the […]

White House Pulls the Plug on Proposed Drug-Rebate Overhaul | Bloomberg

White House Pulls the Plug on Proposed Drug-Rebate Overhaul | Bloomberg

The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. President Donald Trump has made lowering prescription-drug costs a top priority of his administration, and ending rebates was seen as a […]

White House Pulls the Plug on Proposed Drug-Rebate Overhaul | Bloomberg

White House Pulls the Plug on Proposed Drug-Rebate Overhaul | Bloomberg

The White House abandoned a push to end rebates paid to middlemen who negotiate drug prices on behalf of health insurers, a move that could turn scrutiny back on how drugmakers themselves set prices. President Donald Trump has made lowering prescription-drug costs a top priority of his administration, and ending rebates was seen as a […]

Consumer-Focused Pricing Strategies Lacking | HealthLeaders Media

Consumer-Focused Pricing Strategies Lacking | HealthLeaders Media

A new report shows 12% percent of organizations offer no pricing transparency options at all. Hospitals and health systems are neglecting price transparency and market-driven pricing strategies, finds a survey of more than 200 executives. Kaufman Hall’s report, 2019 State of Consumerism in Healthcare: The Bar Is Rising, finds that 12% percent of organizations offer […]

Rebate rule good only for Big Pharma | San Antonio Express-News

Rebate rule good only for Big Pharma | San Antonio Express-News

As a pharmacist for 40 years in San Antonio, I have seen the impact rising prescription drug prices have on patients. Drug prices have soared over the last two decades, which has put untold financial stress and added health complications onto thousands of Texas families and seniors. Too often, patients will hand their medications back […]

States Call for Transparency From PBMs Following Report About Spread Pricing | BioSpace

States Call for Transparency From PBMs Following Report About Spread Pricing | BioSpace

Days after a Scripps Research study supported the argument that the rebate system controlled in part by Pharmacy Benefits Managers (PBMs) has led to an increase in higher drug prices, some state governments are now moving toward greater regulation of the industry. Massachusetts and some other states are pursuing action to increase oversight of PBMs […]

International Pricing Index for Medicare Part B Drugs | The Incidental Economist

International Pricing Index for Medicare Part B Drugs | The Incidental Economist

The Centers for Medicare & Medicaid Services (CMS) has proposed the International Pricing Index (IPI) model as a way of addressing the rising costs of prescription drugs for Medicare beneficiaries. What is it and how would it work? First some background: How is Medicare’s drug coverage currently structured? Medicare offers prescription drug coverage to its […]

How to bring down the high cost of prescription drugs now | missoulian

How to bring down the high cost of prescription drugs now | missoulian

Americans pay the highest brand-name drug prices in the world while drug companies rake in billions. Congress, the administration and Montana state legislators must take action to lower prescription drug prices. In March, AARP launched a nationwide campaign urging federal and state policymakers to “Stop Rx Greed” by cracking down on price-gouging. AARP’s goal is […]

A $2.1 Million Drug Price Record Is Made to Be Broken | The Washington Post

A $2.1 Million Drug Price Record Is Made to Be Broken | The Washington Post

The record $2.1 million price tag for Novartis AG’s gene therapy Zolgensma – a one-time treatment for a deadly childhood disease that was approved by the Food and Drug Administration on Friday – evokes two very different responses. Critics see out-of-control pricing behavior. Supporters say the sticker-shocked are ignoring the creation of a possible cure for a disease that kills children before their second […]

WHO Adopts Weakened Resolution on Drug Price Transparency | RAPS

WHO Adopts Weakened Resolution on Drug Price Transparency | RAPS

The World Health Organization (WHO) on Tuesday adopted a resolution to urge countries to publicly share the net prices of health products and the costs of clinical trials. The resolution, adopted after three weeks of negotiations, also calls on United Nations member countries to better facilitate the public reporting of patent status information and marketing […]